Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study

To identify the optimal treatment for rheumatoid arthritis (RA) after the regression of lymphoproliferative disorders (LPDs). The subjects were 232 patients with RA who developed LPD between 2000 and 2017 at seven hospitals participating in the LPD-WG study. Kaplan-Meier and Cox proportional regress...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Modern rheumatology 2022-01, Vol.ahead-of-print (ahead-of-print), p.1-14
Hauptverfasser:	Nakano, Kazuhisa, Tanaka, Yoshiya, Saito, Kazuyoshi, Kaneko, Yuko, Saito, Shuntaro, Tanaka, Masao, Saito, Rintaro, Fujii, Takao, Kuramoto, Nobuo, Sugimoto, Naoki, Takada, Hideto, Harigai, Masayoshi, Sasaki, Sho, Suzuki, Yasuo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy biological disease-modifying antirheumatic drugs (bDMARDs) Humans Lymphoproliferative Disorders - chemically induced Lymphoproliferative Disorders - etiology Methotrexate Neoplasm Recurrence, Local - chemically induced Neoplasm Recurrence, Local - complications Neoplasm Recurrence, Local - drug therapy Other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIID-LPDs) relapse Retrospective Studies rheumatoid arthritis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!